Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 28,658 | 46,940 | 30,648 | 7,559 | 4,000 |
| Gross Profit | 28,658 | 46,940 | 30,648 | 7,559 | 4,000 |
| Operating Expenses | 66,065 | 61,694 | 64,542 | 48,016 | 51,964 |
| Operating Income | -37,407 | -14,754 | -33,894 | -40,457 | -47,964 |
| Interest Expense | 268 | 0 | 0 | 0 | 0 |
| Other Income | 174 | 108 | 177 | 87 | 104 |
| Pre-tax Income | -37,501 | -14,646 | -33,717 | -40,370 | -47,860 |
| Net Income Continuous | -37,501 | -14,646 | -33,717 | -40,370 | -47,860 |
| Net Income | $-37,501 | $-14,646 | $-33,717 | $-40,370 | $-47,860 |
| EPS Basic Total Ops | -0.97 | -0.41 | -1.24 | -2.30 | -4.30 |
| EPS Basic Continuous Ops | -0.97 | -0.41 | -1.24 | -2.23 | -4.06 |
| EPS Diluted Total Ops | -0.97 | -0.41 | -1.24 | -2.30 | -4.30 |
| EPS Diluted Continuous Ops | -0.97 | -0.41 | -1.24 | -2.23 | -4.06 |
| EBITDA(a) | $-36,818 | $-14,264 | $-33,461 | $-39,866 | $-46,667 |